questionsmedicales.fr
Actions chimiques et utilisations
Actions pharmacologiques
Utilisations thérapeutiques
Agents régulateurs de la reproduction
Fécondostimulants
Fécondostimulants : Questions médicales fréquentes
Termes MeSH sélectionnés :
Neoplasm Recurrence, Local
Diagnostic
5
Infertilité
Tests hormonaux
Réserve ovarienne
Hormone antimüllérienne
Infertilité
Spécialiste de la fertilité
Ovulation
Cycles menstruels
Symptômes
5
Infertilité
Cycles menstruels
Déséquilibre hormonal
Symptômes
Ovulation
Cycles menstruels
Maladie des ovaires
Infertilité
Prévention
5
Toxines
Santé reproductive
Traitements
5
Fécondostimulants
Clomifène
Gonadotrophines
Infertilité
Effets secondaires
Fécondostimulants
Stimulation ovarienne
Échographie
Complications
5
Syndrome d'hyperstimulation
Grossesses multiples
Syndrome d'hyperstimulation
Symptômes
Grossesses multiples
Complications
Grossesses multiples
Naissances prématurées
Effets à long terme
Cancer ovarien
Facteurs de risque
5
Facteurs de risque
Infertilité
Antécédents familiaux
Infertilité
Maladies chroniques
Fertilité
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Fécondostimulants : Questions médicales les plus fréquentes",
"headline": "Fécondostimulants : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Fécondostimulants : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-30",
"dateModified": "2025-02-24",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Fécondostimulants"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Agents régulateurs de la reproduction",
"url": "https://questionsmedicales.fr/mesh/D012102",
"about": {
"@type": "MedicalCondition",
"name": "Agents régulateurs de la reproduction",
"code": {
"@type": "MedicalCode",
"code": "D012102",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.705"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Fécondostimulants féminins",
"alternateName": "Fertility Agents, Female",
"url": "https://questionsmedicales.fr/mesh/D005300",
"about": {
"@type": "MedicalCondition",
"name": "Fécondostimulants féminins",
"code": {
"@type": "MedicalCode",
"code": "D005300",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.705.552.344"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Fécondostimulants masculins",
"alternateName": "Fertility Agents, Male",
"url": "https://questionsmedicales.fr/mesh/D005303",
"about": {
"@type": "MedicalCondition",
"name": "Fécondostimulants masculins",
"code": {
"@type": "MedicalCode",
"code": "D005303",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.705.552.510"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Fécondostimulants",
"alternateName": "Fertility Agents",
"code": {
"@type": "MedicalCode",
"code": "D005299",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "N Chabbert-Buffet",
"url": "https://questionsmedicales.fr/author/N%20Chabbert-Buffet",
"affiliation": {
"@type": "Organization",
"name": "Centre de fertilité Tenon, hôpital Tenon, Sorbonne université, AP-HP, Paris, France. Electronic address: nathalie.chabbert-buffet@aphp.fr."
}
},
{
"@type": "Person",
"name": "N Sermondade",
"url": "https://questionsmedicales.fr/author/N%20Sermondade",
"affiliation": {
"@type": "Organization",
"name": "Centre de fertilité Tenon, hôpital Tenon, Sorbonne université, AP-HP, Paris, France."
}
},
{
"@type": "Person",
"name": "E Moreau",
"url": "https://questionsmedicales.fr/author/E%20Moreau",
"affiliation": {
"@type": "Organization",
"name": "Centre de fertilité Tenon, hôpital Tenon, Sorbonne université, AP-HP, Paris, France."
}
},
{
"@type": "Person",
"name": "S Cristofari",
"url": "https://questionsmedicales.fr/author/S%20Cristofari",
"affiliation": {
"@type": "Organization",
"name": "Centre de fertilité Tenon, hôpital Tenon, Sorbonne université, AP-HP, Paris, France."
}
},
{
"@type": "Person",
"name": "N Johnson",
"url": "https://questionsmedicales.fr/author/N%20Johnson",
"affiliation": {
"@type": "Organization",
"name": "Centre de fertilité Tenon, hôpital Tenon, Sorbonne université, AP-HP, Paris, France."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Classification of Local Recurrence After Nipple-Sparing Mastectomy Based on Location: The Features of Nipple-Areolar Recurrence Differ from Those of Other Local Recurrences.",
"datePublished": "2022-11-13",
"url": "https://questionsmedicales.fr/article/36371582",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1245/s10434-022-12760-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Feasibility of local therapy for recurrent pancreatic cancer.",
"datePublished": "2022-05-24",
"url": "https://questionsmedicales.fr/article/35641368",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.pan.2022.05.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "Ultrasound Assessment of Skin Tumors Local Recurrence.",
"datePublished": "2023-05-17",
"url": "https://questionsmedicales.fr/article/37195073",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jum.16255"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pathological determinants of outcome following resection of locally advanced or locally recurrent rectal cancer.",
"datePublished": "2023-06-26",
"url": "https://questionsmedicales.fr/article/37442715",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejso.2023.06.023"
}
},
{
"@type": "ScholarlyArticle",
"name": "Intraparenchymal metastases as a cause for local recurrence of pancreatic cancer.",
"datePublished": "2022-11-21",
"url": "https://questionsmedicales.fr/article/36371607",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/his.14839"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Actions chimiques et utilisations",
"item": "https://questionsmedicales.fr/mesh/D020164"
},
{
"@type": "ListItem",
"position": 3,
"name": "Actions pharmacologiques",
"item": "https://questionsmedicales.fr/mesh/D020228"
},
{
"@type": "ListItem",
"position": 4,
"name": "Utilisations thérapeutiques",
"item": "https://questionsmedicales.fr/mesh/D045506"
},
{
"@type": "ListItem",
"position": 5,
"name": "Agents régulateurs de la reproduction",
"item": "https://questionsmedicales.fr/mesh/D012102"
},
{
"@type": "ListItem",
"position": 6,
"name": "Fécondostimulants",
"item": "https://questionsmedicales.fr/mesh/D005299"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Fécondostimulants - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Fécondostimulants",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Fécondostimulants",
"description": "Comment diagnostiquer l'infertilité ?\nQuels tests pour évaluer la réserve ovarienne ?\nQuand consulter un spécialiste de la fertilité ?\nQuels signes indiquent un problème d'ovulation ?\nComment évaluer la qualité du sperme ?",
"url": "https://questionsmedicales.fr/mesh/D005299?mesh_terms=Neoplasm+Recurrence,+Local#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Fécondostimulants",
"description": "Quels symptômes d'infertilité chez la femme ?\nQuels signes d'infertilité chez l'homme ?\nComment reconnaître un déséquilibre hormonal ?\nQuels symptômes d'ovulation irrégulière ?\nQuels symptômes d'une maladie des ovaires ?",
"url": "https://questionsmedicales.fr/mesh/D005299?mesh_terms=Neoplasm+Recurrence,+Local#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Fécondostimulants",
"description": "Comment prévenir l'infertilité ?\nQuel rôle de l'alimentation sur la fertilité ?\nComment le stress affecte-t-il la fertilité ?\nPourquoi éviter les toxines environnementales ?\nQuel impact de l'âge sur la fertilité ?",
"url": "https://questionsmedicales.fr/mesh/D005299?mesh_terms=Neoplasm+Recurrence,+Local#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Fécondostimulants",
"description": "Quels sont les principaux fécondostimulants ?\nComment fonctionne le clomifène ?\nQuand utiliser des gonadotrophines ?\nQuels effets secondaires des fécondostimulants ?\nComment se déroule une stimulation ovarienne ?",
"url": "https://questionsmedicales.fr/mesh/D005299?mesh_terms=Neoplasm+Recurrence,+Local#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Fécondostimulants",
"description": "Quelles complications des fécondostimulants ?\nComment reconnaître le syndrome d'hyperstimulation ?\nQuels risques de grossesses multiples ?\nQuelles sont les conséquences d'une grossesse multiple ?\nQuels effets à long terme des fécondostimulants ?",
"url": "https://questionsmedicales.fr/mesh/D005299?mesh_terms=Neoplasm+Recurrence,+Local#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Fécondostimulants",
"description": "Quels facteurs de risque d'infertilité ?\nQuel impact des antécédents familiaux ?\nComment le poids influence-t-il la fertilité ?\nQuel rôle des maladies chroniques ?\nComment l'environnement influence-t-il la fertilité ?",
"url": "https://questionsmedicales.fr/mesh/D005299?mesh_terms=Neoplasm+Recurrence,+Local#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'infertilité ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'infertilité se diagnostique par des tests hormonaux, échographies et analyses de sperme."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer la réserve ovarienne ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se fait par la mesure de l'hormone antimüllérienne (AMH) et l'échographie."
}
},
{
"@type": "Question",
"name": "Quand consulter un spécialiste de la fertilité ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé de consulter après un an d'essais infructueux pour les couples de moins de 35 ans."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un problème d'ovulation ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des cycles irréguliers, des règles absentes ou des douleurs pelviennes peuvent indiquer un problème."
}
},
{
"@type": "Question",
"name": "Comment évaluer la qualité du sperme ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La qualité du sperme est évaluée par une analyse de sperme, mesurant la concentration et la motilité."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'infertilité chez la femme ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des cycles irréguliers, des douleurs pelviennes et des règles absentes."
}
},
{
"@type": "Question",
"name": "Quels signes d'infertilité chez l'homme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes peuvent inclure des problèmes d'érection, des douleurs testiculaires ou des anomalies du sperme."
}
},
{
"@type": "Question",
"name": "Comment reconnaître un déséquilibre hormonal ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme l'acné, la prise de poids ou des changements d'humeur peuvent indiquer un déséquilibre."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'ovulation irrégulière ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des cycles menstruels irréguliers et des douleurs pelviennes peuvent signaler une ovulation irrégulière."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une maladie des ovaires ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs pelviennes, des règles irrégulières et des problèmes de fertilité."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'infertilité ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un poids santé, éviter le tabac et gérer le stress peuvent aider à prévenir l'infertilité."
}
},
{
"@type": "Question",
"name": "Quel rôle de l'alimentation sur la fertilité ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée riche en antioxydants et en acides gras oméga-3 peut améliorer la fertilité."
}
},
{
"@type": "Question",
"name": "Comment le stress affecte-t-il la fertilité ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut perturber les cycles hormonaux et affecter l'ovulation, réduisant ainsi la fertilité."
}
},
{
"@type": "Question",
"name": "Pourquoi éviter les toxines environnementales ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les toxines peuvent nuire à la qualité du sperme et à la santé reproductive, augmentant le risque d'infertilité."
}
},
{
"@type": "Question",
"name": "Quel impact de l'âge sur la fertilité ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé réduit la qualité des ovules et la fertilité, surtout après 35 ans chez les femmes."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux fécondostimulants ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux fécondostimulants incluent le clomifène, les gonadotrophines et l'acide folique."
}
},
{
"@type": "Question",
"name": "Comment fonctionne le clomifène ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le clomifène stimule l'ovulation en bloquant les récepteurs d'œstrogènes dans l'hypothalamus."
}
},
{
"@type": "Question",
"name": "Quand utiliser des gonadotrophines ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les gonadotrophines sont utilisées lorsque le clomifène est inefficace ou en cas d'infertilité sévère."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires des fécondostimulants ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des bouffées de chaleur, des nausées et des douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Comment se déroule une stimulation ovarienne ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La stimulation ovarienne implique des injections de médicaments et un suivi échographique régulier."
}
},
{
"@type": "Question",
"name": "Quelles complications des fécondostimulants ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure le syndrome d'hyperstimulation ovarienne et des grossesses multiples."
}
},
{
"@type": "Question",
"name": "Comment reconnaître le syndrome d'hyperstimulation ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs abdominales, des nausées et un gain de poids rapide après traitement."
}
},
{
"@type": "Question",
"name": "Quels risques de grossesses multiples ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les fécondostimulants augmentent le risque de grossesses multiples, ce qui peut entraîner des complications."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une grossesse multiple ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les grossesses multiples peuvent entraîner des naissances prématurées et des complications pour la mère."
}
},
{
"@type": "Question",
"name": "Quels effets à long terme des fécondostimulants ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets à long terme peuvent inclure des risques accrus de cancer ovarien, bien que les données soient limitées."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque d'infertilité ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, des antécédents médicaux, le tabagisme et l'obésité."
}
},
{
"@type": "Question",
"name": "Quel impact des antécédents familiaux ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antécédents familiaux d'infertilité peuvent augmenter le risque d'infertilité chez les individus."
}
},
{
"@type": "Question",
"name": "Comment le poids influence-t-il la fertilité ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un poids excessif ou insuffisant peut perturber les cycles hormonaux et affecter la fertilité."
}
},
{
"@type": "Question",
"name": "Quel rôle des maladies chroniques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des maladies comme le diabète ou le syndrome des ovaires polykystiques peuvent affecter la fertilité."
}
},
{
"@type": "Question",
"name": "Comment l'environnement influence-t-il la fertilité ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exposition à des produits chimiques et à des toxines peut nuire à la qualité reproductive."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 24/02/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Centre de fertilité Tenon, hôpital Tenon, Sorbonne université, AP-HP, Paris, France. Electronic address: nathalie.chabbert-buffet@aphp.fr.
Publications dans "Fécondostimulants" :
2 publications dans cette catégorie
Affiliations :
Centre de fertilité Tenon, hôpital Tenon, Sorbonne université, AP-HP, Paris, France.
Publications dans "Fécondostimulants" :
2 publications dans cette catégorie
Affiliations :
Centre de fertilité Tenon, hôpital Tenon, Sorbonne université, AP-HP, Paris, France.
Publications dans "Fécondostimulants" :
2 publications dans cette catégorie
Affiliations :
Centre de fertilité Tenon, hôpital Tenon, Sorbonne université, AP-HP, Paris, France.
Publications dans "Fécondostimulants" :
2 publications dans cette catégorie
Affiliations :
Centre de fertilité Tenon, hôpital Tenon, Sorbonne université, AP-HP, Paris, France.
Publications dans "Fécondostimulants" :
2 publications dans cette catégorie
Affiliations :
Centre de fertilité Tenon, hôpital Tenon, Sorbonne université, AP-HP, Paris, France.
Publications dans "Fécondostimulants" :
2 publications dans cette catégorie
Affiliations :
GREI Specialist, Department of Obstetrics and Gynaecology, Mount Sinai Fertility, Sinai Health System, Toronto, ON.
Publications dans "Fécondostimulants" :
2 publications dans cette catégorie
Publications dans "Fécondostimulants" :
2 publications dans cette catégorie
Affiliations :
Division of Animal Sciences, and Department of Obstetrics, Gynecology and Women's Health, University of Missouri, Columbia, MO, USA. sutovskyp@missouri.edu.
Publications dans "Fécondostimulants" :
2 publications dans cette catégorie
Affiliations :
Centre de Recherche en Reproduction, Développement et Santé Intergénérationnelle (CRDSI), Département des Sciences Animales, Faculté des Sciences de l'Agriculture et de l'Alimentation, Université Laval, Québec, Québec, Canada; State Key Laboratory of Reproductive Regulation & Breeding of Grassland livestock, College of Life Science, Inner Mongolia University, Hohhot, China.
Publications dans "Fécondostimulants" :
1 publication dans cette catégorie
Affiliations :
Laboratory for Advanced Carbon Nanomaterials, Chemical Institute, Kazan Federal University, Kremlevskaya St. 18, Kazan 420008, Russian Federation.
Laboratory "Materials for Green Energy and Sustainability", Kazan Federal University, Kremlevskaya St. 18, Kazan 420008, Russian Federation.
Publications dans "Fécondostimulants" :
1 publication dans cette catégorie
Affiliations :
"RPC BASV" Ltd., Kalinin St. 6, Suite 34, Kazan 420043, Russian Federation.
Publications dans "Fécondostimulants" :
1 publication dans cette catégorie
Affiliations :
Laboratory for Advanced Carbon Nanomaterials, Chemical Institute, Kazan Federal University, Kremlevskaya St. 18, Kazan 420008, Russian Federation.
Publications dans "Fécondostimulants" :
1 publication dans cette catégorie
Affiliations :
Institute of Environmental Sciences, Kazan Federal University, Kremlevskaya St. 18, Kazan 420008, Russian Federation.
Publications dans "Fécondostimulants" :
1 publication dans cette catégorie
Affiliations :
Institute of Environmental Sciences, Kazan Federal University, Kremlevskaya St. 18, Kazan 420008, Russian Federation.
Publications dans "Fécondostimulants" :
1 publication dans cette catégorie
Affiliations :
Institute of Environmental Sciences, Kazan Federal University, Kremlevskaya St. 18, Kazan 420008, Russian Federation.
Publications dans "Fécondostimulants" :
1 publication dans cette catégorie
Affiliations :
Institute of Environmental Sciences, Kazan Federal University, Kremlevskaya St. 18, Kazan 420008, Russian Federation.
Publications dans "Fécondostimulants" :
1 publication dans cette catégorie
Affiliations :
Laboratory for Advanced Carbon Nanomaterials, Chemical Institute, Kazan Federal University, Kremlevskaya St. 18, Kazan 420008, Russian Federation.
Laboratory "Materials for Green Energy and Sustainability", Kazan Federal University, Kremlevskaya St. 18, Kazan 420008, Russian Federation.
Publications dans "Fécondostimulants" :
1 publication dans cette catégorie
Affiliations :
Universidade Estadual do Ceará, Fortaleza, CE, Brazil.
Publications dans "Fécondostimulants" :
1 publication dans cette catégorie
Affiliations :
Centro Universitário Christus Unichristus, Fortaleza, CE, Brazil.
Publications dans "Fécondostimulants" :
Little information is available about the clinical and pathologic characteristics of local recurrence (LR) after nipple-sparing mastectomy according to the locations of LR....
This study classified 99 patients into the following two groups according to the location of LR after nipple-sparing mastectomy: nipple-areolar recurrence (NAR) group and other locations of LR (oLR) g...
For about half of the patients (44.4 %) with NAR, the primary cancer was estrogen receptor (ER)-negative and human epidermal growth factor receptor 2 (HER2)-positive. Conversely, in most of the patien...
This multi-institutional retrospective study demonstrated that the features of NAR, such as the characteristics of the primary and recurrent tumors and the prognostic factors after LR resection, were ...
Despite advances in perioperative management, recurrence after curative pancreatectomy is a critical issue in the treatment of pancreatic ductal adenocarcinoma (PDAC). The significance of local therap...
We reviewed the medical records of patients with PDAC who underwent curative resection at our institution between January 2009 and December 2019. We examined the patterns of relapse and assessed the c...
A total of 246 patients with PDAC who underwent R0 or R1 resection were included in this study. The 3-year overall survival (OS) rate was 39.8%, and the 1-year recurrence-free survival rate was 51.2% ...
Our results suggest that a multimodal approach may improve the clinical outcomes of patients with recurrent PDAC....
Skin cancer may recur at or around the surgical site despite wide excisions. Prompt clinical and sonographic detection of local recurrence is important since subjects with relapsing melanomas or nonme...
Pathological factors that influence and predict survival following pelvic exenteration (PE) for locally advanced (LARC) or locally recurrent rectal cancer (LRRC), especially LRRC, remain poorly unders...
A retrospective cohort study was performed for all patients undergoing a curative PE for LARC or LRRC between 2008 and 2021 at a tertiary referral UK specialist colorectal hospital. Cox regression ana...
388 patients were included in the analysis with 256 resections for LARC and 132 for LRRC. 62.4% of patients were male with a median age of 59 years (IQR 49-67). 247 (64%) partial pelvic exenterations ...
A positive resection margin and poorly differentiated tumours are significant negative prognostic markers for survival and recurrence in LARC. The results of this study support the need to look for al...
Using CODA, a technique for three-dimensional reconstruction of large tissues, Kiemen et al. report observation of a microscopic focus of pancreatic cancer found in the vasculature of grossly normal h...
The initial approach to the treatment of desmoid tumors has changed from surgical resection to watchful waiting. However, surgery is still sometimes considered for some patients, and it is likely that...
We sought to explore whether a combined molecular and clinical prognostic model for relapse in patients with desmoid tumors treated with surgery would allow us to identify patients who might do well w...
This was a retrospective, single-center study of 107 patients with desmoid tumors who were surgically treated between January 1980 and December 2015, with a median follow-up of 106 months (range 7 to ...
The multivariable analysis showed that S45F mutations (hazard ratio 5.25 [95% confidence interval 2.27 to 12.15]; p < 0.001) and tumor in the extremities (HR 3.15 [95% CI 1.35 to 7.33]; p = 0.008) wer...
CTNNB1 S45F mutations combined with other clinical variables are a potential prognostic biomarker associated with the risk of relapse in patients with desmoid tumors. The developed nomogram is simple ...
Level III, therapeutic study....
A first local recurrence is common after resection or radiotherapy for brain metastasis (BM). However, patients with BMs can develop multiple local recurrences over time. Published data on second loca...
Patients were identified from a database at Brigham and Women's Hospital in Boston. Hazard ratios and 95% confidence intervals for predictors of a second local recurrence were computed using a Cox pro...
Of 170 identified surgically treated first locally recurrent lesions, 74 (43.5%) progressed to second locally recurrent lesions at a median of 7 months after craniotomy. Subtotal resection of the firs...
A second local recurrence occurred after 43.5% of craniotomies for first recurrent lesions. Subtotal resection and infratentorial location were the strongest risk factors for worse second local recurr...
The current study was undertaken to provide more detailed prognostic models for early prediction of local recurrences and local recurrence free survival (RFS) using different radiologic and pathologic...
One hundred patients with locally advanced rectal carcinomas decided to receive neoadjuvant CRT were retrospectively recruited, Hazard ratios (HR) were determined in the two cox regression models and ...
HR of 1st group of models: T+N, T+N+G, T+N+G+S, T+N+G+S+PNI, and T+N+G+S+PNI+R were summated and categorized into scores, these scores were significantly correlated with the risk of recurrence (Somer'...
We propose that the addition of biologic factors to staging of rectal cancer provide precise stratification and association with local recurrences in patients received preoperative CRT....
This study aims to identify prognostic factors and define the best extent of surgery for optimizing treatment of local recurrence (LR) following colorectal cancer (CRC)....
An institutional database of consecutive patients who underwent radical resection (R0/R1) of LR following CRC was analyzed prospectively from 2010 to 2021 at one tertiary cancer center....
In this study, 75 patients were included with LR following CRC and analyzed. Patients were categorized as compartmental resections (CompRe) (n = 47) if all adjacent organs were systematically removed,...
Complete compartmental surgery is safe and improves local control. Optimal LR resection needs to remove all contiguous organs, with or without tumor involvement....
RET-fused mesenchymal neoplasms mostly affect the soft tissue of paediatric patients. Given their responsiveness to selective RET inhibitors, it remains critical to identify those extraordinary cases ...
Clinicopathological features were assessed and partner agnostic targeted next-generation sequencing on clinically validated platforms were performed. The patients were 18, 53, and 55 years old and inc...
Our study expands the clinicopathological and genetic spectrum of mesenchymal neoplasms associated with RET fusions....